Pharmacy and Poisons Board recalls substandard batches of Paracetamol, Augmentin
In a statement released on Thursday, the Chief Executive Officer, Fred Siyoi, revealed the detection of several compromised batches of injectable Paracetamol, falsified Augmentin drugs, and a product mix-up involving Esomeprazole.
The Pharmacy and Poisons Board (PPB) has issued an urgent warning to Kenyans over the presence of substandard and falsified medicines circulating in the market, raising serious public health concerns.
In a statement released on Thursday, the Chief Executive Officer, Fred Siyoi, revealed the detection of several compromised batches of injectable Paracetamol, falsified Augmentin drugs, and a product mix-up involving Esomeprazole.
More To Read
The three batches are as follows:
Paracetamol Injection: Three brands of Paracetamol 1000mg/100ml injections have exhibited unusual colour changes, prompting fears over their safety and efficacy. The affected products include: Lumidol Injection—Batch Numbers CM4594007, CM4594008, CM4594009, Blink Injection—Batch Numbers C84594005, CS4594004 and Paragen Injection—Batch Number K4290027.
All these injections were manufactured by KamlaAmrut Pharmaceutical LLP, India.
Esomeprazole Pack: The Board also confirmed a case of product mix-up involving S-Prazo (Esomeprazole 40mg), Batch No. SPZ404, where a strip of Levofloxacin 500mg tablets was discovered inside a pack meant for Esomeprazole capsules—a potentially harmful error for unsuspecting patients.
Augmentin: Further investigations have also uncovered falsified Augmentin in the market. The specific products in question are AUGMENTIN 1G – Batch SGS2 and AUGMENTIN 625mg – Batch Numbers 8X3K and EU7C.
“The Pharmacy and Poisons Board urges all pharmaceutical outlets, healthcare providers, and members of the public to immediately stop distributing, selling, issuing, or using the affected product batches. Anyone in possession of the flagged drugs is advised to return them to the nearest healthcare facility or supplier.”
The Board encourages Kenyans to report any suspected cases of substandard medicines or adverse drug reactions to nearby health facilities or directly to the PPB through its reporting channels.
Top Stories Today
